Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Molecular Cancer Research is Scopus-indexed (Q1, CiteScore 9.6), WoS SCIE. Published by American Association for Cancer Research Inc..
Checked against the index lists dated .
ISSN 1541-7786Verify ISSN ↗1557-3125Verify ISSN ↗
Publisher: American Association for Cancer Research Inc.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 57 / 428 | 86th | Q1 |
| Molecular Biology | 70 / 414 | 83rd | Q1 |
| Cancer Research | 52 / 233 | 77th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2002–present, best quartile Q1, CiteScore 9.6.
Molecular Cancer Research is Q1 in Oncology (rank 57 of 428), Q1 in Molecular Biology (rank 70 of 414) and Q1 in Cancer Research (rank 52 of 233), by CiteScore 2025.
Molecular Cancer Research is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 9.6, which places it in quartile Q1 at the 86th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.759, quartile Q1, with an H-index of 162.
Molecular Cancer Research is published by American Association for Cancer Research Inc. Its print ISSN is 1541-7786 and its online ISSN is 1557-3125.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Molecular Cancer Research has an h-index of 158 and a 2-year mean of 3.09 citations per paper (OpenAlex). Its Scopus CiteScore is 9.6, quartile Q1. On 2-year citations it ranks #105 of 424 Scopus journals in Oncology.
Molecular Cancer Research published 85 papers in 2025; its busiest recent year was 2020 with 508. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 81 research articles (2025–2026), authors are most often from United States (48.6%), China (30.2%) and Japan (3.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 34 retracted papers are recorded (6.8 per 1,000 papers). The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.